Nektar Therapeutics (BMV:NKTR)

Nektar Therapeutics Statistics

Total Valuation

BMV:NKTR has a market cap or net worth of MXN 21.06 billion. The enterprise value is 19.18 billion.

Market Cap	21.06B
Enterprise Value	19.18B

Important Dates

The next estimated earnings date is Wednesday, February 25, 2026.

Earnings Date	Feb 25, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	19.02M
Shares Outstanding	n/a
Shares Change (YoY)	+14.07%
Shares Change (QoQ)	+34.49%
Owned by Insiders (%)	0.76%
Owned by Institutions (%)	65.25%
Float	18.91M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	18.34
PB Ratio	13.49
P/TBV Ratio	13.49
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-8.66
EV / Sales	16.84
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.49

Financial Position

The company has a current ratio of 4.24, with a Debt / Equity ratio of 1.96.

Current Ratio	4.24
Quick Ratio	4.09
Debt / Equity	1.96
Debt / EBITDA	n/a
Debt / FCF	-0.88
Interest Coverage	-5.13

Financial Efficiency

Return on equity (ROE) is -180.24% and return on invested capital (ROIC) is -33.61%.

Return on Equity (ROE)	-180.24%
Return on Assets (ROA)	-27.97%
Return on Invested Capital (ROIC)	-33.61%
Return on Capital Employed (ROCE)	-58.03%
Revenue Per Employee	18.82M
Profits Per Employee	-36.30M
Employee Count	61
Asset Turnover	0.21
Inventory Turnover	n/a

Taxes

Income Tax	-7.85M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +34.35% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+34.35%
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	61.19
Average Volume (20 Days)	108

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.87

Income Statement

In the last 12 months, BMV:NKTR had revenue of MXN 1.15 billion and -2.21 billion in losses. Loss per share was -144.90.

Revenue	1.15B
Gross Profit	1.00B
Operating Income	-2.50B
Pretax Income	-2.22B
Net Income	-2.21B
EBITDA	-2.48B
EBIT	-2.50B
Loss Per Share	-144.90

Balance Sheet

The company has 4.96 billion in cash and 3.06 billion in debt, giving a net cash position of 1.89 billion.

Cash & Cash Equivalents	4.96B
Total Debt	3.06B
Net Cash	1.89B
Net Cash Per Share	n/a
Equity (Book Value)	1.56B
Book Value Per Share	79.41
Working Capital	3.94B

Cash Flow

In the last 12 months, operating cash flow was -3.48 billion and capital expenditures -11.23 million, giving a free cash flow of -3.49 billion.

Operating Cash Flow	-3.48B
Capital Expenditures	-11.23M
Free Cash Flow	-3.49B
FCF Per Share	n/a

Margins

Gross margin is 87.26%, with operating and profit margins of -217.83% and -192.87%.

Gross Margin	87.26%
Operating Margin	-217.83%
Pretax Margin	-193.55%
Profit Margin	-192.87%
EBITDA Margin	-215.97%
EBIT Margin	-217.83%
FCF Margin	n/a

Dividends & Yields

BMV:NKTR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.07%
Shareholder Yield	-14.07%
Earnings Yield	-10.52%
FCF Yield	-16.58%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 9, 2025. It was a reverse split with a ratio of 0.0666666667.

Last Split Date	Jun 9, 2025
Split Type	Reverse
Split Ratio	0.0666666667

Scores

BMV:NKTR has an Altman Z-Score of -16.94 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-16.94
Piotroski F-Score	3